购物车
- 全部删除
- 您的购物车当前为空
R-10015 是一种高效选择性 LIMK 抑制剂,通过结合 ATP 结合口袋阻断 LIMK,抑制人 LIMK1 的 IC50值为 38 nM。它还发挥广谱抗病毒作用,可用于 HIV 感染研究。
为众多的药物研发团队赋能,
让新药发现更简单!
R-10015 是一种高效选择性 LIMK 抑制剂,通过结合 ATP 结合口袋阻断 LIMK,抑制人 LIMK1 的 IC50值为 38 nM。它还发挥广谱抗病毒作用,可用于 HIV 感染研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 488 | 现货 | |
5 mg | ¥ 1,190 | 现货 | |
10 mg | ¥ 1,890 | 现货 | |
25 mg | ¥ 3,590 | 现货 | |
50 mg | ¥ 4,970 | 现货 | |
100 mg | ¥ 6,780 | 现货 | |
200 mg | ¥ 9,170 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,310 | 现货 |
产品描述 | R-10015 is a highly potent and selective LIMK inhibitor that blocks LIMK by binding to the ATP-binding pocket. It inhibits human LIMK1 with an IC50 value of 38 nM. It also exerts broad-spectrum antiviral effects and may be used in HIV infection research. |
靶点活性 | LIMK1 (human):38 nM |
体外活性 | R10015 as a lead compound that blocks LIMK activity by binding to the ATP-binding pocket.?R10015 specifically blocks viral DNA synthesis, nuclear migration, and virion release.?In addition, R10015 inhibits multiple viruses, including Zaire ebolavirus (EBOV), Rift Valley fever virus (RVFV), Venezuelan equine encephalitis virus (VEEV), and herpes simplex virus 1 (HSV-1), suggesting that LIMK inhibitors could be developed as a new class of broad-spectrum antiviral drugs. |
分子量 | 410.86 |
分子式 | C20H19ClN6O2 |
CAS No. | 2097938-51-5 |
Smiles | COC(=O)c1ccc2nc([nH]c2c1)C1CCN(CC1)c1ncnc2[nH]cc(Cl)c12 |
密度 | 1.465 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 62.5 mg/mL (152.12 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容